Activities in the field of rare diseases in Slovakia. CISARIK František Faculty Hospital Žilina

Size: px
Start display at page:

Download "Activities in the field of rare diseases in Slovakia. CISARIK František Faculty Hospital Žilina"

Transcription

1 Activities in the field of rare diseases in Slovakia CISARIK František Faculty Hospital Žilina

2 As we progress? Slovak National Strategy for the Development of Health Care for Patients with Rare Diseases was adopted by Government of the Slovak Republic on 24 October 2012 (Národná stratégia rozvoja zdravotnej starostlivosti o pacientov so zriedkavými chorobami na roky UZNESENIE VLÁDY SLOVENSKEJ REPUBLIKY č. 578 z 24. októbra 2012 )

3 Vision Alliance for RD in Slovakia Commission of the MH of the SR for RD Adoption of criteria for CE European reference network Financial support for RD activities RD registers

4 Vision Alliance for RD in Slovakia Commission of MH of the SR for RD Statute of the Commission of the MH of the Slovak Republic for RD was adopted by the Minister on 24.november 2014 Štatút Komisie Ministdrstva zdravotníctva Slovenskej republiky pre zriedkavé choroby (Rare Diseases RD)

5 Upgraded concept of health care in the field of medical genetics has been adopted by the MH on January 31, 2014 Koncepcia zdravotnej starostlivosti v odbore lekárska genetika, Číslo: S01260-OZS-2014 Dňa: 31. januára 2014

6 Professional guidance document of the Ministry of Health on the standardization of genetic diagnostics of syndrome of hereditary breast and ovarian carcinoma (HBOC) is just before approval

7 National Newborn Screening Centre + 3 regional Recall Centres providing definitive diagnostic procedures and continuous management of confirmed cases Professional guidance of the Ministry of Health of nationwide screening for congenital hypothyroidism, congenital adrenal hyperplasia, cystic fibrosis and certain inherited metabolic disorders in newborns and health care for captured cases November 16, 2012

8 Newborn screening expanded (2012) panel of screened diseases from 4 congenital hypothyroidism, phenylketonuria, congenital adrenal hyperplasia, and cystic fibrosis to 13, to include hyperphenylalaninemia(hpa), leucinosis (MSUD), MCAD, LCHAD, VLCAD, CPT I., CPT II.A, CACT, glutaric aciduria type I (GA I), and isovaleric aciduria (IVA). Od 1. januára 2013 na Slovensku vyšetrujeme v skríningu dedičných metabolických porúch metódou tandemovej hmotnostnej spektrometrie LC- MS/MS nasledovné ochorenia: FKU/HPA, MSUD leucinózu, MCAD deficit acyl CoA dehydrogenázy MK so stredným reťazcom, VLCAD - deficit acyl CoA dehydrogenázy MK s veľmi dlhým reťazcom, LCHAD - deficit 3OH acyl CoA dehydrogenázy MK s dlhým reťazcom, CPT I. deficit karnitínpalmitoyltransferázy I., CPT II/CACT - deficit karnitínpalmitoyltransferázy II/deficit karnitín acylkarnitíntranslokázy, GA.I. glutarová acidúria I, IVA izovalerová acidúria.

9 Basic pillars of the national plan European reference network Research Centres of expertise Quality control Therapy Registries of RD

10 National Registry of Congenital Anomalies Why we decided to use National Registry of Congenital Anomalies as platform for development of Registry of Rare Diseases in Slovakia? Why with substantial cooperation with clinical geneticists now? 1. This Registry of Congenital Anomalies has had a long and successful history in Slovakia. The data have been published since Over these years, the registry has undergone more changes in the system of reporting as significant changes in discovering aetiological connection with congenital anomalies took place.

11 Why we decided to use National Registry of Congenital Anomalies as platform for development of Registry of Rare Diseases in Slovakia? Why with substantial cooperation with clinical geneticists now? 2. As 85% of rare diseases are genetic and a lot of congenital anomalies are genetically conditioned, we were looking for the possibilities of using the existing registries run by the National Health Information Centre to create a virtual registry of rare diseases. In fact, the existing National Registry of Congenital Anomalies appears to be the closest in its nature. 3. On the other hand, provision of medical genetics services in the Slovak Republic has now well established organisational structure, network of providers, personnel and methodical conditions, which ensure high-level services.

12 Year 2013 : Number of CH.A. according to type of risk PRENATALLY DETECTED CHROMOSOMAL ANOMALY RISK of CH.A/ No of cases DS T18 T13 GA Other All Age over 35 years/ screening negative- (745) Positive screening (1968) Ultrasonography (338) Genetic clasical (113) Other risk (74) Alltogether (3252) DS=Down sy., T18=trisomy 18, T13=trisomy 13, GA= gonosomal anamaly, Other= other chromosomal anomalies Genetic register SR Registry of prenatally diagnosed genetic diseases Clinical geneticists have experience with so-called Genetic registry SR, which was run under Slovak Society of Medical Genetics for more than 10 years. Another long term registry run under Slovak Society of Medical Genetics is Registry of Prenatal Genetic Diagnosis (prenatally diagnosed genetic disorders), which we organize for 20 years.

13 Pilot steps in creation Registry of Rare diseases According to Act No. 153/2013 on the National Health Information System and on Amendments and Additions to Certain Laws, since 2014, The National Registry of Patients with Congenital Anomalies consists of: Registry of Congenital Anomalies (all congenital anomalies including inherited and genetic disorders and rare diseases). Registry of Congenital Heart Defects (specific reporting). New reporting forms: Report on Congenital Anomalies in Live Births and Stillbirths (filed in by neonatologists and pedatricians, till now without ORPHA codes) Report on Congenital Anomalies Inherited Diseases, Genetic Disorders and Rare Diseases (new report filed in by clinical geneticists, using ICD 10, OMIM and ORPHA codes ) Report on Congenital Anomalies of the Foetus Genetics (new report filed in by clinical geneticists,using ICD 10, OMIM and ORPHA codes )

14 LIST OF NATIONAL HEALTH REGISTRIES National Registry of Electronic Health Records National Cancer Registry National Diabetes Mellitus Registry National Congenital Disease Registry National Cardiovascular Registry National Registry of Neurological Disorders National Registry of Chronic Pulmonary Disease National Tuberculosis Registry National Arthroplasty Registry National Registry of Patients with Inflammatory Rheumatic Disease National Registry of Persons with Injury Requiring Inpatient Healthcare National Registry of Persons Suspected of Being Neglected, Abused and on Victims of Violence

15 Ďakujem za pozornosť

State of the Art of Rare Disease Activities in EU Member States and Other European Countries. Slovak Republic Report

State of the Art of Rare Disease Activities in EU Member States and Other European Countries. Slovak Republic Report State of the Art of Rare Disease Activities in EU Member States and Other European Countries Slovak Republic Report Definition of a Rare Disease The Slovak Republic has adopted the European Commission

More information

Overview of Newborn Screening, Potential Uses of Residual Dried Blood Spots, and Protection of Privacy

Overview of Newborn Screening, Potential Uses of Residual Dried Blood Spots, and Protection of Privacy Overview of Newborn Screening, Potential Uses of Residual Dried Blood Spots, and Protection of Privacy Alan R. Fleischman, M.D. Senior Vice President and Medical Director Chair, Federal Advisory Committee,

More information

State of the Art of Rare Disease - Activities in EU Member States and Other European Countries. Belgium Report

State of the Art of Rare Disease - Activities in EU Member States and Other European Countries. Belgium Report State of the Art of Rare Disease - Activities in EU Member States and Other European Countries Definition of a Rare Disease Belgium Report The definition of rare diseases in the Belgian Plan for Rare Diseases

More information

Newborn Screening: Focus on Treatment

Newborn Screening: Focus on Treatment Newborn Screening: Focus on Treatment Alan R. Fleischman, M.D. Senior Vice President and Medical Director March of Dimes National Conference of State Legislatures July 21, 2008 Newborn Screening: A Public

More information

[R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS DEPARTMENT OF HEALTH. February October October 1992 (E) September 1995

[R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS DEPARTMENT OF HEALTH. February October October 1992 (E) September 1995 RULES AND REGULATIONS PERTAINING TO THE NEWBORN METABOLIC, ENDOCRINE, AND HEMOGLOBINOPATHY SCREENING PROGRAM AND THE NEWBORN HEARING LOSS SCREENING PROGRAM [R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE

More information

Title: Assessing Recommendations Related To Timeliness of Newborn Screening

Title: Assessing Recommendations Related To Timeliness of Newborn Screening Title: Assessing Recommendations Related To Timeliness of Newborn Screening Purpose: In January 2014, the Secretary s Discretionary Advisory Committee on Heritable Diseases on Newborns and Children (Committee)

More information

Positive Newborn Screens: What do you do next?

Positive Newborn Screens: What do you do next? Positive Newborn Screens: What do you do next? James B. Gibson, MD, Ph.D. Biochemical Geneticist at Specially for Children Clinical Associate Professor of Pediatrics UTHSCSA Carla R. Scott, MD Pediatric

More information

Newborn Bloodspot Screening Information for parents

Newborn Bloodspot Screening Information for parents Newborn Bloodspot Screening Information for parents You will be offered a bloodspot screening test for your newborn baby for several rare but serious conditions. The sample for this test is usually taken

More information

Newborn Bloodspot Screening Information for parents

Newborn Bloodspot Screening Information for parents Newborn Bloodspot Screening Information for parents You will be offered a bloodspot screening test for your newborn baby for several rare but serious conditions. The sample for this test is usually taken

More information

(f) "Birthing center" means any facility that is licensed by the Georgia Department of Community Health as a birthing center;

(f) Birthing center means any facility that is licensed by the Georgia Department of Community Health as a birthing center; Ga. Comp. R. & Regs. r. 511-5-5-.02 Definitions Rule 511-5-5-.02. Definitions (a) "Abnormal test result" is a test result from blood testing or physiologic monitoring that is outside the screening limits

More information

State of the Art of Rare Disease Activities in EU Member States and Other European Countries Croatia Report

State of the Art of Rare Disease Activities in EU Member States and Other European Countries Croatia Report State of the Art of Rare Disease Activities in EU Member States and Other European Countries Croatia Report Definition of a Rare Disease Croatia has adopted the European Commission definition of a rare

More information

For the Ongoing Management of Babies under 1 year old.

For the Ongoing Management of Babies under 1 year old. Pathway Author: Nicy Turney, Senior Nurse Professional Lead, Health Visiting 19.06.17 For the Ongoing Management of Babies under 1 year old. Check Health Records (CHR) to undertake daily checks to identify:

More information

Slide 1: Newborn Bloodspot Screening for Medium-chain Acyl-CoA Dehydrogenase Deficiency (MCADD)

Slide 1: Newborn Bloodspot Screening for Medium-chain Acyl-CoA Dehydrogenase Deficiency (MCADD) Slide 1: Newborn Bloodspot Screening for Medium-chain Acyl-CoA Dehydrogenase Deficiency (MCADD) The information has been produced with thanks to the NHS Newborn Blood Spot Screening Programme. 1 Slide

More information

TIMELINESS OF NEWBORN SCREENING: RECOMMENDATIONS FROM ADVISORY COMMITTEE ON HERITABLE DISORDERS IN NEWBORNS AND CHILDREN

TIMELINESS OF NEWBORN SCREENING: RECOMMENDATIONS FROM ADVISORY COMMITTEE ON HERITABLE DISORDERS IN NEWBORNS AND CHILDREN TIMELINESS OF NEWBORN SCREENING: RECOMMENDATIONS FROM ADVISORY COMMITTEE ON HERITABLE DISORDERS IN NEWBORNS AND CHILDREN Susan Tanksley, PhD May 19, 2015 TIMELINESS - BACKGROUND In order to effectively

More information

State of the Art of Rare Disease - Activities in EU Member States and Other European Countries. Portugal Report

State of the Art of Rare Disease - Activities in EU Member States and Other European Countries. Portugal Report State of the Art of Rare Disease - Activities in EU Member States and Other European Countries Definition of a Rare Disease Portugal Report Portugal has adopted the European Commission definition of a

More information

Newborn Genetic Testing & Surveillance System

Newborn Genetic Testing & Surveillance System Georgia Newborn Genetic Testing & Surveillance System State GA Statute/ Rule STATUTE: Chapter 1 Chapter 2 Chapter 12 Title 33 Chapter 54 RULE: 290-5-.02 and 290-5- 24 Language Specific to Genetic Testing

More information

NEWBORN SCREENING. in Massachusetts: Answers for You and Your Baby. University of Massachusetts Medical School

NEWBORN SCREENING. in Massachusetts: Answers for You and Your Baby. University of Massachusetts Medical School University of Massachusetts Medical School NEWBORN SCREENING in Massachusetts: Answers for You and Your Baby New England Newborn Screening Program Biotech 4, 2nd Floor UMass Medical School 377 Plantation

More information

Further expansion of the neonatal screening panel in the Netherlands

Further expansion of the neonatal screening panel in the Netherlands Further expansion of the neonatal screening panel in the Netherlands J.Gerard Loeber APHL-NBSGT, St.Louis (MO), USA 290216 Population Area Newborns 6.01 million 0.35:1 16.8 million 180,693 sq km 4.3:1

More information

Health Chapter ALABAMA STATE BOARD OF HEALTH ALABAMA DEPARTMENT OF PUBLIC HEALTH BUREAU OF FAMILY HEALTH SERVICES ADMINISTRATIVE CODE

Health Chapter ALABAMA STATE BOARD OF HEALTH ALABAMA DEPARTMENT OF PUBLIC HEALTH BUREAU OF FAMILY HEALTH SERVICES ADMINISTRATIVE CODE ALABAMA STATE BOARD OF HEALTH ALABAMA DEPARTMENT OF PUBLIC HEALTH BUREAU OF FAMILY HEALTH SERVICES ADMINISTRATIVE CODE CHAPTER 420-10-1 CARE AND TREATMENT OF INFANTS IDENTIFIED THROUGH THE NEWBORN SCREENING

More information

For Your Baby s Health Department of Health

For Your Baby s Health Department of Health Newborn Screening For Your Baby s Health Department of Health Why is my baby tested? To help make sure your baby will be as healthy as possible. The blood test provides important information about your

More information

The Compelling Benefits of Routine 2 nd NBS: A Fifteen-Year Review in Washington State. Saving lives with a simple blood spot

The Compelling Benefits of Routine 2 nd NBS: A Fifteen-Year Review in Washington State. Saving lives with a simple blood spot The Compelling Benefits of Routine 2 nd NBS: A Fifteen-Year Review in Washington State Caroline T. Nucup-Villaruz, MD Primary Author NBS Consultant - Disorder FU Santosh Shaunak Co-Author & Presenter Laboratory

More information

Routine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015

Routine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015 Routine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015 Metabolic birth defects can cause physical problems, mental retardation and, in some cases, death. It is

More information

Centres of reference for rare diseases expectations based on Polish experience. Małgorzata Krajewska-Walasek

Centres of reference for rare diseases expectations based on Polish experience. Małgorzata Krajewska-Walasek Centres of reference for rare diseases expectations based on Polish experience Małgorzata Krajewska-Walasek Department of Medical Genetics, The Children s Memorial Health Institute, Warsaw, Poland My presentation

More information

BULGARIAN NATIONAL PLAN. Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD)

BULGARIAN NATIONAL PLAN. Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD) BULGARIAN NATIONAL PLAN FOR RARE DISEASES 2009 2013 Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD) Strategy for rare diseases in Bulgaria Project of National

More information

Community Genetics. Hanan Hamamy Department of Genetic Medicine & Development Geneva University Hospital

Community Genetics. Hanan Hamamy Department of Genetic Medicine & Development Geneva University Hospital Community Genetics Hanan Hamamy Department of Genetic Medicine & Development Geneva University Hospital Training Course in Sexual and Reproductive Health Research Geneva 2011 Definition of Community Genetics

More information

Newborn Screening in Manitoba. Information for Health Care Providers

Newborn Screening in Manitoba. Information for Health Care Providers Newborn Screening in Manitoba Information for Health Care Providers Newborn screening: a healthy start leads to a healthier life Health care professionals have provided newborn screening for phenylketonuria

More information

Newborn Metabolic Screening Programme Annual Report

Newborn Metabolic Screening Programme Annual Report Newborn Metabolic Screening Programme Annual Report January to December 2015 Disclaimer This publication reports on information provided to the Ministry of Health by the Auckland District Health Board.

More information

Newborn Screening & Methods for Diagnosing Inborn Errors of Metabolism

Newborn Screening & Methods for Diagnosing Inborn Errors of Metabolism Newborn Screening & Methods for Diagnosing Inborn Errors of Metabolism Patricia Jones, PhD DABCC FACB UT Southwestern Medical Center Children s Medical Center Dallas, Texas Learning Objectives Justify

More information

Health and Wellness for all Arizonans. azdhs.gov

Health and Wellness for all Arizonans. azdhs.gov To identify newborns with certain, rare disorders and assist families of affected infants so that they receive appropriate and timely treatment to prevent or delay serious medical problems. To identify

More information

Newborn Metabolic Screening Programme. Annual Report

Newborn Metabolic Screening Programme. Annual Report Newborn Metabolic Screening Programme Annual Report January to December 2016 1 Disclaimer This publication reports on information provided to the Ministry of Health by the Auckland District Health Board.

More information

UK Newborn Screening for X-ALD - progress from a lab perspective

UK Newborn Screening for X-ALD - progress from a lab perspective UK Newborn Screening for X-ALD - progress from a lab perspective Mrs. Leila Cornes Senior Clinical Scientist, Newborn Screening Southmead Hospital, Bristol May 2016 C26:0-lysoPC C26:0-lysophosphatidylcholine

More information

Newborn Screening: Blood Spot Disorders

Newborn Screening: Blood Spot Disorders Newborn Screening: Blood Spot Disorders Arizona s Newborn Screening Program Program Overview Panel of Disorders Disorder Descriptions Program Components Hospitals ADHS Lab ADHS Follow-up ADHS Billing Medical

More information

Inborn Errors of Metabolism From Neonatal Screening to Metabolic Pathways

Inborn Errors of Metabolism From Neonatal Screening to Metabolic Pathways 19 May 2015 Hospital Authority Convention 2015 Corporate Scholarship Presentation II Paediatric Services Inborn Errors of Metabolism From Neonatal Screening to Metabolic Pathways Dr Grace Poon Associate

More information

Annual Report Calendar Year 2015

Annual Report Calendar Year 2015 Annual Report Calendar Year 2015 Page 1 of 19 Contents 1. SAMPLE VOLUMES IN 2015...3 1.1 SCREENING SAMPLES...3 1.1.1 INFANTS SCREENED...3 1.1.2 DECLINED/DEFERRED TESTING...4 1.1.3 MISSED SCREENS...5 1.2

More information

Atlas of Genetics and Cytogenetics in Oncology and Haematology

Atlas of Genetics and Cytogenetics in Oncology and Haematology Atlas of Genetics and Cytogenetics in Oncology and Haematology Neonatal Screening I - INTRODUCTION 1- Neonatal screening for a metabolic disease must address a frequent pathology for which there is an

More information

How MS/MS Revolutionized Newborn Screening

How MS/MS Revolutionized Newborn Screening How MS/MS Revolutionized Newborn Screening David S Millington, PhD Medical Research Professor of Pediatrics Director, Biochemical Genetics Laboratory Duke University Medical Center NEWBORN SCREENING IN

More information

A Guide for Prenatal Educators

A Guide for Prenatal Educators A Guide for Prenatal Educators Why Teach Newborn Screening This booklet is designed to make it easy for you, a prenatal educator, to effectively inform expectant parents about newborn screening. All of

More information

Newborn Metabolic Screening Programme

Newborn Metabolic Screening Programme Newborn Metabolic Screening Programme Annual Report January to December 2017 Released 2018 health.govt.nz Disclaimer This publication reports on information provided to the Ministry of Health by the Auckland

More information

Comprehensive cost-utility analysis of newborn screening strategies Carroll A E, Downs S M

Comprehensive cost-utility analysis of newborn screening strategies Carroll A E, Downs S M Comprehensive cost-utility analysis of newborn screening strategies Carroll A E, Downs S M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS

More information

Information for health professionals

Information for health professionals Introduction of a new screening test for newborn babies in Wales Newborn bloodspot screening for Medium chain acyl-coa dehydrogenase deficiency (MCADD) Newborn bloodspot screening for MCADD is being introduced

More information

Post mortem investigation of Inherited Metabolic Disease - the last opportunity for a diagnosis -

Post mortem investigation of Inherited Metabolic Disease - the last opportunity for a diagnosis - Post mortem investigation of Inherited Metabolic Disease - the last opportunity for a diagnosis - Dr Simon Olpin Lead Clinical Scientist in Inherited Metabolic Disease Sheffield Children s Hospital SIDS/SUDI

More information

DIAGNOSIS OF FATTY ACID OXIDATION DISORDERS BY MASS SPECTROMETRY

DIAGNOSIS OF FATTY ACID OXIDATION DISORDERS BY MASS SPECTROMETRY DIAGNOSIS OF FATTY ACID OXIDATION DISORDERS BY MASS SPECTROMETRY Eric Law Chemical Pathology, PWH 15 January 2010 Outline of talk Basic of mitochondrial fatty acid oxidation (FAO) Laboratory investigations

More information

Newborn Screening: What s New?

Newborn Screening: What s New? Newborn Screening: What s New? Patricia M. Jones, PhD (Department of Pathology, University of Texas Southwestern Medical Center and Children s Medical Center of Dallas, Dallas, TX) DOI: 10.1309/LMOOXWVPSM5FC3B6

More information

Most common is the congenital adrenogenital syndrome (AGS) or congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.

Most common is the congenital adrenogenital syndrome (AGS) or congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. Newborn Screening Examination parameters: TSH-neonatal (hypothyreosis), 17-OH progesterone (AGS), galactose (galactosemia), galactose-uridyl transferase (galacto semia), biotinidase (biotinidase ), phenylalanine

More information

NEWBORN SCREENING. in Massachusetts: Information for You and Your Baby. University of Massachusetts Medical School

NEWBORN SCREENING. in Massachusetts: Information for You and Your Baby. University of Massachusetts Medical School University of Massachusetts Medical School NEWBORN SCREENING in Massachusetts: Information for You and Your Baby New England Newborn Screening Program Biotech 4, 2nd Floor UMass Medical School 377 Plantation

More information

Newborn Screening in Japan: Restructuring for the New Era

Newborn Screening in Japan: Restructuring for the New Era Plenary 13 Newborn Screening in Japan: Restructuring for the New Era Seiji Yamaguchi, 1 MD Abstract Nationwide neonatal mass screening for inherited metabolic diseases has started in Japan since 1977.

More information

MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES

MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES NEWBORN SCREENING Protecting your newborn MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES [ 1 ] NEWBORN SCREENING [ 2 ] FREQUENTLY ASKED QUESTIONS [ 4 ] DISORDERS INCLUDED IN NEWBORN SCREENING [ 12 ]

More information

Information for health professionals

Information for health professionals Changes to the Newborn Bloodspot Screening Policy for Congenital Hypothyroidism (CHT) in Preterm Babies A UK policy change has been agreed that will mean changes to: which preterm babies require second

More information

Alvaro Serrano Russi MD University of Iowa Hospitals and Clinics

Alvaro Serrano Russi MD University of Iowa Hospitals and Clinics Retrospective Analysis of the Region 4 Post Analytical Tool and Confirmatory Testing for Long Chain Fatty Acid Oxidation Disorders Screened in the State of Iowa Alvaro Serrano Russi MD University of Iowa

More information

Assessing Mothers Knowledge of the Wisconsin Newborn Screening Program. Sara Wolfgram UW Master of Public Health Symposium August 11, 2006

Assessing Mothers Knowledge of the Wisconsin Newborn Screening Program. Sara Wolfgram UW Master of Public Health Symposium August 11, 2006 Assessing Mothers Knowledge of the Wisconsin Newborn Screening Program Sara Wolfgram UW Master of Public Health Symposium August 11, 2006 Background Wisconsin Newborn Screening (NBS): Began in 1965 Heel

More information

NEWBORN SCREENING. health.mo.gov/newbornscreening MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES

NEWBORN SCREENING. health.mo.gov/newbornscreening MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES NEWBORN SCREENING health.mo.gov/newbornscreening MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES Table of Contents NEWBORN SCREENING...1 FREQUENTLY ASKED QUESTIONS...2 DISORDERS INCLUDED IN NEWBORN SCREENING...4

More information

NEWBORN METABOLIC SCREEN, MINNESOTA

NEWBORN METABOLIC SCREEN, MINNESOTA Lab Dept: Test Name: Chemistry NEWBORN METABOLIC SCREEN, MINNESOTA General Information Lab Order Codes: Synonyms: CPT Codes: Test Includes: PKUN Newborn Screen for Hyopothyroidism, Phenylketonuria (PKU),

More information

Annual Report Calendar Year 2014

Annual Report Calendar Year 2014 Annual Report Calendar Year 2014 1 Contents 1. SAMPLE VOLUMES IN 2014...4 1.1 SCREENING SAMPLES...4 1.1.1 INFANTS SCREENED...4 1.1.2 DECLINED/DEFERRED TESTING...5 1.1.3 MISSED SCREENS...6 1.2 NON-SCREENING

More information

Newborn screening for additional metabolic diseases using second-tier strategies Juergen G. Okun, PhD

Newborn screening for additional metabolic diseases using second-tier strategies Juergen G. Okun, PhD Newborn screening for additional metabolic diseases using second-tier strategies Juergen G. Okun, PhD 5th EFLM-UEMS European Joint Congress in Laboratory Medicine 10-13 October 2018 in Antalya, Turkey

More information

SLOVAK BEER AND MALT ASSOCIATION RESPONSIBILITY DAY

SLOVAK BEER AND MALT ASSOCIATION RESPONSIBILITY DAY SLOVAK BEER AND MALT ASSOCIATION RESPONSIBILITY DAY Report from the Health and Education Campaign Brussels, 23 November 2012 Campaign Information Aim of Responsibility Day : to prevent excessive alcohol

More information

Blue represents coding updates. G0389 with diagnosis V81.2, V15.82, or with diagnosis V79.1, or

Blue represents coding updates. G0389 with diagnosis V81.2, V15.82, or with diagnosis V79.1, or An Independent Licensee of the Blue Cross and Blue Shield Association Preventive Care Services The following is a list of preventive services (HCP rider) along with the diagnoses and procedure codes that

More information

National. Screening Report. Germany 2016

National. Screening Report. Germany 2016 National Screening Report Germany 2016 German Society for Neonatal Screening (DGNS) Uta Nennstiel, Anja Lüders, Oliver Blankenstein, Uta Ceglarek, Regina Ensenauer, Gwendolyn Gramer, Nils Janzen, Jeannette

More information

National. Screening Report. Germany 2014

National. Screening Report. Germany 2014 National Screening Report Germany 2014 German Society for Neonatal Screening (DGNS) Uta Nennstiel-Ratzel, Anja Lüders, Oliver Blankenstein, Uta Ceglarek, Regina Ensenauer, Gwendolyn Gramer, Jeannette Klein,

More information

Slide 1: The information has been produced with thanks to the NHS Newborn Blood Spot Screening Programme.

Slide 1: The information has been produced with thanks to the NHS Newborn Blood Spot Screening Programme. Slide 1: The information has been produced with thanks to the NHS Newborn Blood Spot Screening Programme. 1 Slide 2: Aim 2 Slide 3: Objectives 3 Slide 4: What is the aim of newborn bloodspot screening?

More information

The EU rare diseases policy framework: the context for ERNs

The EU rare diseases policy framework: the context for ERNs The EU rare diseases policy framework: the context for ERNs Jaroslaw Waligora DG Health and Food Safety, European Commission Unit C.1, Programme Management and Diseases Report from an expert group of the

More information

National. Screening Report Deutsche Gesellschaft für Neugeborenenscreening DGNS

National. Screening Report Deutsche Gesellschaft für Neugeborenenscreening DGNS National Report 2007 Deutsche Gesellschaft für Neugeborenenscreening DGNS Dr. med. Uta Nennstiel-Ratzel MPH, Dr. med. Anja Lüders MPH, Dr. med. Oliver Blankenstein, Dr. rer. nat. Uta Ceglarek, Dr. med.

More information

NEWBORN SCREENING IN JAPAN

NEWBORN SCREENING IN JAPAN NEWBORN SCREENING IN JAPAN Kikurnaro Aoki KagawaNutrition University, Saitama, Japan Abstract. In the 19701s, the government began to take steps for the treatment of congenital diseases. Mass newborn screening

More information

ERNDIM QA Scheme for qualitative blood spot acylcarnitine analysis. Annual Report 2010

ERNDIM QA Scheme for qualitative blood spot acylcarnitine analysis. Annual Report 2010 UniversitätsKlinikum Heidelberg Universitätsklinik für Kinder- und Jugendmedizin Stoffwechselzentrum Heidelberg Stoffwechsellabor Im Neuenheimer Feld 430 69120 Heidelberg To Stoffwechselzentrum Heidelberg

More information

HONG KONG COLLEGE OF PAEDIATRICIANS. Proposal of the service model & training programme of Metabolic Medicine

HONG KONG COLLEGE OF PAEDIATRICIANS. Proposal of the service model & training programme of Metabolic Medicine HONG KONG COLLEGE OF PAEDIATRICIANS Committee for Subspecialty Boards Forum on the Impact of Hong Kong Children s Hospital on the future paediatric training and service Proposal of the service model &

More information

State of the Art of Rare Disease Activities in EU Member States and Other European Countries. Hungary Report

State of the Art of Rare Disease Activities in EU Member States and Other European Countries. Hungary Report State of the Art of Rare Disease Activities in EU Member States and Other European Countries Definition of a Rare Disease Hungary Report Hungary has adopted the European Commission definition of a rare

More information

Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis)

Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis) Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis) 1) Argininosuccinic acidemia (ASA) a) Incidence: ~1 in 70,000 b) Deficiency in an enzyme of

More information

Selective newborn screening of amino acid, fatty acid and organic acid disorders in the Kingdom of Bahrain.

Selective newborn screening of amino acid, fatty acid and organic acid disorders in the Kingdom of Bahrain. Selective newborn screening of amino acid, fatty acid and organic acid disorders in the Kingdom of Bahrain. Jamal Golbahar PhD Associate Professor of Molecular Medicine, Department of Molecular Medicine,

More information

Fatty Acid Oxidation Disorders Organic Acid Disorders

Fatty Acid Oxidation Disorders Organic Acid Disorders Genetic Fact Sheets for Parents Fatty Acid Oxidation Disorders Organic Acid Disorders Screening, Technology, and Research in Genetics is a multi-state project to improve information about the financial,

More information

Annual Report to the Newborn Screening Ontario Advisory Council Calendar Year 2017

Annual Report to the Newborn Screening Ontario Advisory Council Calendar Year 2017 Annual Report to the Newborn Screening Ontario Advisory Council Calendar Year 2017 415 Smyth Road, Ottawa Ontario K1H 8M8 Phone: 6137383222 1877NBS8330 Fax: 6137380853 Contents 1. SAMPLE VOLUMES IN 2017...4

More information

Newborn Bloodspot Screening (NBS) Training for Health Visitors. December 2017

Newborn Bloodspot Screening (NBS) Training for Health Visitors.   December 2017 Newborn Bloodspot Screening (NBS) Training for Health Visitors www.newbornbloodspotscreening.wales.nhs.uk December 2017 Aims To enable you to gain a clear understanding of the following: Aim and rationale

More information

History of Metabolic Tests. Dr Mick Henderson Biochemical Genetics Leeds and Manchester

History of Metabolic Tests. Dr Mick Henderson Biochemical Genetics Leeds and Manchester History of Metabolic Tests Dr Mick Henderson Biochemical Genetics Leeds and Manchester This presentation Wont just be a history lesson But there will be some of that! Hopefully will give an impression

More information

Subject: Preventive Services Policy Effective Date: 08/2017 Revision Date: 05/2018

Subject: Preventive Services Policy Effective Date: 08/2017 Revision Date: 05/2018 Subject: Preventive s Policy Effective Date: 08/2017 Revision Date: 05/2018 DESCRIPTION The Affordable Care Act (ACA) requires nongrandfathered health plans to cover evidence-based preventive care and

More information

Attachment 1. Newborn Screening Program Description

Attachment 1. Newborn Screening Program Description Attachment 1 Newborn Screening Program Description The core mission of Texas Newborn Screening Program is to save children s lives through the early detection of life-threatening disorders. 34 Newborn

More information

Disclosures. Update on Medical Genetics for Family Practitioners. Objectives. Genetic Testing. Types of Genetic Tests. Dogma of Genetics 08/05/2018

Disclosures. Update on Medical Genetics for Family Practitioners. Objectives. Genetic Testing. Types of Genetic Tests. Dogma of Genetics 08/05/2018 Update on Medical Genetics for Family Practitioners Genetic Testing, Newborn Screening, and Direct to Consumer Testing Sandhya Parkash, MD, FRCPC, FCCMG Maritime Medical Genetics Service, IWK Health Centre

More information

Genetic counselling in PGD

Genetic counselling in PGD Genetic counselling in PGD Sérgio Castedo Serviço de Genética Faculdade de Medicina do Porto scastedo@netcabo.pt Disclosure of interests Sérgio Castedo is the CEO of GDPN, a private genetics diagnostic

More information

2013 REPORT ON THE STATE OF THE ART OF RARE DISEASE ACTIVITIES IN EUROPE

2013 REPORT ON THE STATE OF THE ART OF RARE DISEASE ACTIVITIES IN EUROPE 2013 REPORT ON THE STATE OF THE ART OF RARE DISEASE ACTIVITIES IN EUROPE STATE OF THE ART OF RARE DISEASE ACTIVITIES IN CYPRUS This work was financed by the EUCERD Joint Action: Working for Rare Diseases

More information

Newborn Screening in Washington State Saving lives with a simple blood spot

Newborn Screening in Washington State Saving lives with a simple blood spot Newborn Screening in Washington State Saving lives with a simple blood spot Ashleigh Ragsdale, MPH Gauri Gupta, MScPH Objectives Newborn Screening Overview Process and Law Completing Collection Cards Video

More information

Flow of samples and information for newborn screening in a model of publicprivate

Flow of samples and information for newborn screening in a model of publicprivate Flow of samples and information for newborn screening in a model of publicprivate partnership Marzia Pasquali, PhD, FACMG Associate Professor of Pathology, University of Utah Medical Director, Biochemical

More information

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 12/19/17 SECTION: MEDICINE LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 12/19/17 SECTION: MEDICINE LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE: MEDICAL FOODS Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs are

More information

Preventive Care Services Summary

Preventive Care Services Summary Preventive Care Services Summary Below is a list of preventive services along with the diagnoses and procedure codes that Community Health Options has determined to meet or exceed the requirements and

More information

National. Screening Report 2008 DGNS

National. Screening Report 2008 DGNS National Report 2008 DGNS Deutsche Gesellschaft für Neugeborenenscreening e.v. Dr. med. Uta Nennstiel-Ratzel MPH, Dr. med. Anja Lüders MPH, Dr. med. Oliver Blankenstein, Dr. rer. nat. Uta Ceglarek, Dr.

More information

SUNY Downstate Medical Center -University Hospital of Brooklyn Network Department of Pathology Policy and Procedure

SUNY Downstate Medical Center -University Hospital of Brooklyn Network Department of Pathology Policy and Procedure SUNY Downstate Medical Center -University Hospital of Brooklyn Network Department of Pathology Policy and Procedure Subject: NEWBORN SCREENING FOR METABOLIC DEFICIENCIES Prepared By: Yolaine Henry Edit

More information

What is the Experience of Family Physicians Regarding Patient s Clinical Genetic Questions?

What is the Experience of Family Physicians Regarding Patient s Clinical Genetic Questions? What is the Experience of Family Physicians Regarding Patient s Clinical Genetic Questions? Rick Kellerman, MD, John Dorsch, MD, Doug Woolley, MD, MPH, Terry Ast, BA Department of Family and Community

More information

Inborn Errors of Metabolism Clinical Approach to Diagnosis and Treatment

Inborn Errors of Metabolism Clinical Approach to Diagnosis and Treatment Case Scenario: 15 year old girl presented in ED with aggressive behaviour and hallucinations. No associated fever, vomiting, seizures or developmental concerns Previously well Inborn Errors of Metabolism

More information

UK National Screening Committee Screening for Congenital Adrenal Hyperplasia in Children 19 November 2015

UK National Screening Committee Screening for Congenital Adrenal Hyperplasia in Children 19 November 2015 UK National Screening Committee Screening for Congenital Adrenal Hyperplasia in Children 19 November 2015 Aim 1. To ask the UK National Screening Committee to make a recommendation, based upon the evidence

More information

COUNCIL RECOMMENDATION of 2 December 2003 on cancer screening (2003/878/EC)

COUNCIL RECOMMENDATION of 2 December 2003 on cancer screening (2003/878/EC) L 327/34 COUNCIL RECOMMDATION of 2 December 2003 on cancer screening (2003/878/EC) THE COUNCIL OF THE EUROPEAN UNION, Having regard to the Treaty establishing the European Community, and in particular

More information

NEONATAL SCREENING FOR INBORN ERRORS OF METABOLISM OUR EXPERIENCE AT CABRI, GULF MEDICAL UNIVERSITY

NEONATAL SCREENING FOR INBORN ERRORS OF METABOLISM OUR EXPERIENCE AT CABRI, GULF MEDICAL UNIVERSITY GMJ GULF MEDICAL JOURNAL ORAL PROCEEDINGS NEONATAL SCREENING FOR INBORN ERRORS OF METABOLISM OUR EXPERIENCE AT CABRI, GULF MEDICAL UNIVERSITY I.A. Shaafie 1 *, A.D. Vijay Raju 2, P.K. Menon 3 1Division

More information

Fatty Acid Oxidation Disorders- an update. Fiona Carragher Biochemical Sciences, GSTS Pathology St Thomas Hospital, London

Fatty Acid Oxidation Disorders- an update. Fiona Carragher Biochemical Sciences, GSTS Pathology St Thomas Hospital, London Fatty Acid Oxidation Disorders- an update Fiona Carragher Biochemical Sciences, GSTS Pathology St Thomas Hospital, London An update. Overview of metabolism Clinical presentation and outcome Diagnostic

More information

Joshua Hellmann Foundation Newborn Metabolic Screening Program Clinical Protocol

Joshua Hellmann Foundation Newborn Metabolic Screening Program Clinical Protocol Joshua Hellmann Foundation Newborn Metabolic Screening Program Clinical Protocol Centre of Inborn Errors of Metabolism The Chinese University of Hong Kong Version 7 Effective Date: 15 th February 2016

More information

Metabolomic Analysis for Newborn Screening and Diagnosis of Metabolic Disorders

Metabolomic Analysis for Newborn Screening and Diagnosis of Metabolic Disorders Metabolomic Analysis for Newborn Screening and Diagnosis of Metabolic Disorders Mass Spectrometry and Separation Sciences for Laboratory Medicine Chicago October 1-2, 2015 Michael J. Bennett PhD, FRCPath,

More information

Services. Colorado RegionEALTH CARE REFORM UPDATE

Services. Colorado RegionEALTH CARE REFORM UPDATE Health Care Reform Preventive Hpreventive Services Services Colorado Region Colorado RegionEALTH CARE REFORM UPDATE Your guide to preventive services for the Preventive services coverage for over 65 years,

More information

MINISTRY OF HEALTH OF THE REPUBLIC OF CROATIA NATIONAL PROGRAMME FOR RARE DISEASES

MINISTRY OF HEALTH OF THE REPUBLIC OF CROATIA NATIONAL PROGRAMME FOR RARE DISEASES MINISTRY OF HEALTH OF THE REPUBLIC OF CROATIA NATIONAL PROGRAMME FOR RARE DISEASES 2015 2020 Zagreb, February 2015 Contents NATIONAL PROGRAMME... 1 FOR RARE DISEASES 2015 2020... 1 CONTENTS... 2 1. INTRODUCTION...4

More information

Medium-chain acyl-coa dehydrogenase (MCAD) deficiency and Expanded Newborn Screening in Japan

Medium-chain acyl-coa dehydrogenase (MCAD) deficiency and Expanded Newborn Screening in Japan Medium-chain acyl-coa dehydrogenase (MCAD) deficiency and Expanded Newborn Screening in Japan Seiji YAMAGUCHI, MD Department of Pediatrics, Shimane University (co-authors) Jamiyan Purevsuren, Yuki Hasegawa,

More information

Meeting with EMA: cooperation in the field of ERNs. Enrique Terol DG SANTE European Commission

Meeting with EMA: cooperation in the field of ERNs. Enrique Terol DG SANTE European Commission Meeting with EMA: cooperation in the field of ERNs Enrique Terol DG SANTE European Commission London 16 May 2017 The road to European Reference Networks (ERNs) Imagine if the best specialists from across

More information

Considerations in Choosing Screening Conditions: One (US) Approach

Considerations in Choosing Screening Conditions: One (US) Approach 22 Plenary Considerations in Choosing Screening Conditions: One (US) Approach Bradford L Therrell Jr, 1,2 MS, PhD Abstract The lack of a national policy on newborn screening (NBS) in the United States

More information

First Issued: 6/29/2007 Revisions: 12/10/2008, 5/12/2010

First Issued: 6/29/2007 Revisions: 12/10/2008, 5/12/2010 U n i t e d H e a l t h C a r e G u i d e l i n e Division UnitedHealthcare Departments Community Plan Products Children s Rehabilitative Services (CRS) State :Arizona Title: CRS Metabolic Clinical Practice

More information

Purpose. Newborn Screening- UC 260. What is NBS? What isn t NBS? History. History 2

Purpose. Newborn Screening- UC 260. What is NBS? What isn t NBS? History. History 2 Purpose Newborn Screening- UC 260 Edward B. Goldman, J.D. Health System Attorney University of Michigan November 13, 2003 We will review newborn screening (NBS) history Look at current NBS practices Discuss

More information

Counsyl Foresight Carrier Screen. Utmost confidence in every result

Counsyl Foresight Carrier Screen. Utmost confidence in every result Counsyl Foresight Carrier Screen Utmost confidence in every result EXTENDING THE BENEFITS OF CARRIER SCREENING Elevate quality of care with expanded carrier screening (ECS) Carrier screening is used to

More information

Proposal for EXPANDED NEWBORN SCREENING

Proposal for EXPANDED NEWBORN SCREENING Proposal for EXPANDED NEWBORN SCREENING Tel:+971-4-4503875 Fax:+971-4-4503874 DuBiotech, P.O.Box 212671Dubai, UAE. Email: info@easternbiotech.com www.easternbiotech.com Winner of Dubai SME100 Ranked #19

More information

Metabolic Changes in ASD. Norma J. Arciniegas, MD Simón E. Carlo, MD Instituto Filius

Metabolic Changes in ASD. Norma J. Arciniegas, MD Simón E. Carlo, MD Instituto Filius Metabolic Changes in ASD Norma J. Arciniegas, MD Simón E. Carlo, MD Instituto Filius 12 patients 3 Autism: Ages 3/3/3.7 3 PDD: Ages 3/3/6 3 Asperger: Ages 6/7/15.1 3 Speech delay and Sensory Problems (SHL):

More information